IB Net Payout Yields Model

Invest like me - only at Covestor.com

Snap Up More Shares

By -

Update - February 6, 2024

Q4 numbers were solid, but the market isn't happy. Snap is down some 30% after hours despite guiding towards Q1 revenue growth of up to 15%. The stock is a bargain on massive weakness due to the strong move towards subscriptions. 

-Q4 Non-GAAP EPS of $0.08 beats by $0.02.
-Rev of $1.36B (+5% Y/Y) misses by $20M.
-DAUs increased 10% year-over-year to 414 million

Guidance
Rev of $1,095 million to $1,135 million vs $1.12B consensus, implying YoY growth of 11% to 15%.

-Snapchat+, our subscription service that offers exclusive, experimental, and pre-release features grew from 2 million to 7 million subscribers in 2023, and exited the year with an annualized revenue run rate of $249 million.

Original article published on Dec. 21, 2023

  • Snap Inc. shares have doubled in the last quarter and have significant upside potential.
  • The Snapchat+ subscription service has seen explosive growth, with the potential to quickly surpass $500 million in annualized revenue in early 2024.
  • Snap's goal for 2024, including 14 million Snapchat+ subscribers and 20% ad revenue growth, appears achievable.
  • The stock now trades closer to social media sector EV/S multiples, but Snap has substantial upside to growth estimates for 2024 to fuel a further rally.
  • Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our subscriber-only portfolios. Learn More »
Snap Inc. (NYSE:SNAP) shares have doubled in the last quarter, and the stock likely has much more upside. A lot of small and mid-cap stocks were crushed during the last couple of years, providing substantial upside to just return to more normal valuations. My investment thesis remains Bullish on the social messaging stock, though investors clearly missed an opportunity to own Snap at far lower levels.

Read the full article on Seeking Alpha. 

Disclosure: No position mentioned. Please review the disclaimer page for more details. 

Comments

Post a Comment

Popular posts from this blog

Occidental: Still Producing Too Much Oil

By -
Image
Though oil continues plunging, the oil giants continue producing more. For Q4, Occidental Petroleum (OXY) had roughly flat production. The worst part is that OXY plans to grow production by 2% to 4% in 2016. The stock has held up somewhat strong, but the inability to turn off the spigot remains troubling. Disclosure: No positions mentioned. Please review the disclaimer page for more details. 
Read more

ChargePoint: Low Quality Beat

By -
Image
  ChargePoint beat FQ2'22 revenue estimates, but the losses are mounting. The company guided up FY22 numbers partly due to acquisitions. The stock still trades at an estimated 21x FY23 number leaving limited upside for the stock and reinforcing why venture funds sold 13.8 million shares. Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our model portfolio.  Learn More » After  solid FQ2'22 earnings ,  ChargePoint Holdings  ( CHPT ) has seen a nice bump in the stock. Now investors have to confront the valuation divide and deal with the past insider sales likely leading to future sales on any stock rallies. My  investment thesis  remains very Bearish on the EV charging station stock on any rallies into the mid-$20s. Read the full article on Seeking Alpha.  Disclosure: No position mentioned. Please review the disclaimer page for more details.  Update - Sept. 8 Be cautious when analysts struggle to make the bullish case on expen
Read more

Aurora Cannabis: Deal Or No Deal

By -
Aurora Cannabis was left out of the major deal making in 2018. The cannabis company updated FQ2 guidance to revenues of $50 to $55 million with a continued focus on pure production growth. The stock is down as the market is becoming less impressed with commodity farming operations due to the prime Oregon example. The stock is below key resistance at $5.40 as medical cannabis patient totals failed to impress. As the end of 2018 came and went,   Aurora Cannabis   ( ACB ) was a notable absentee from the deal making in the cannabis market. Just about all of the other major Canadian cannabis players got large investments or signed up powerful partnerships, but the related stocks didn't generally maintain rallies following the deals. Based on the early legalization data in Canada and Oregon, the best option for Aurora Cannabis might actually be selling production capacity while the Canadian market remains hot. Read the full article on Seeking Alpha.  Disclosure: No
Read more